Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Dice Therapeutics Inc
(NQ:
DICE
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Aug 8, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
-
Bid (Size)
47.45 (10)
Ask (Size)
47.81 (2)
Prev. Close
47.55
Today's Range
N/A - N/A
52wk Range
N/A - N/A
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
BioMedNewsBreaks — BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) Positioned Favorably with Worldwide License to Anti-IL-17 NanoAbs
September 01, 2023
Via
Investor Brand Network
Exposures
Product Safety
Why These 3 Large Caps Are Bucking the August Slump
August 22, 2023
The three largest S&P 500 outperformers of August are tacking on gains in a weak market, making them intriguing momentum plays to watch for the rest of 2023.
Via
MarketBeat
Topics
Economy
Stocks
Exposures
Fossil Fuels
Interest Rates
US Equities
Performance
More News
Read More
What 9 Analyst Ratings Have To Say About DICE Therapeutics
August 09, 2023
Via
Benzinga
Analyst Expectations for DICE Therapeutics's Future
June 20, 2023
Via
Benzinga
Health Care Company Eli Lilly Announces Acquisition of DICE Therapeutics
June 20, 2023
Via
Benzinga
Top 5 Health Care Stocks That May Crash In Q3
August 07, 2023
Via
Benzinga
Eli Lilly To Report Q2 Earnings: What's In The Cards?
August 05, 2023
Via
Talk Markets
M&A Activity, Booming Sales of Anti-IL-17 Drugs Suggest Strong Upside Potential for BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV)
July 26, 2023
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
Intellectual Property
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
July 17, 2023
Via
Benzinga
DICE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
July 10, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Why Shares of Ventyx Biosciences Rose Monday
July 03, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For June 26, 2023
June 26, 2023
Via
Benzinga
Stock Market Pulls Back After Several Weeks Of Gains: Weekly Review
June 23, 2023
Via
Investor's Business Daily
Why Dice Therapeutics Stock Bolted Higher This Week
June 22, 2023
Via
The Motley Fool
Is Eli Lilly's Dice Therapeutics Acquisition a Needle-Moving Event?
June 21, 2023
Via
The Motley Fool
DICE THERAPEUTICS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of DICE Therapeutics, Inc. - DICE
June 21, 2023
From
Kahn Swick & Foti, LLC
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 21, 2023
June 21, 2023
Via
Benzinga
Red Hot Eli Lilly Rolls the DICE With Its Latest Biotech Takeover
June 21, 2023
Via
MarketBeat
Eli Lilly's $2.4 Billion Acquisition of Dice Therapeutics: What Investors Need to Know
June 20, 2023
Via
The Motley Fool
Crude Oil Down 2%; Dragonfly Energy Shares Plunge
June 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 20, 2023
Via
Benzinga
Dow Dips Over 300 Points; DICE Therapeutics Shares Spike Higher
June 20, 2023
Via
Benzinga
Why Surgalign Holdings Shares Are Trading Lower By Around 75%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
June 20, 2023
Via
Benzinga
Eli Lilly (NYSE: LLY) Acquires DICE Therapeutics (NASDAQ: DICE): A New Step in Autoimmune Disease Treatments
June 20, 2023
Via
Spotlight Growth
Why Shares of Dice Therapeutics Are Skyrocketing Tuesday
June 20, 2023
Via
The Motley Fool
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.